AAP
AMIX

Arax Advisory Partners’s Autonomix Medical AMIX Stock Holding History

Arax Advisory Partners’s Portfolio AMIX Stock Details AMIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-48
Closed -$1.57K – 4362
2025
Q2 		$1.57K Buy
+48
New +$1.72K ﹤0.01% 2645

Other funds holding AMIX

Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
IRC
Investors Research Corp Atlanta, Georgia $559M AUM 21.55% 1-Year Est. Return

Arax Advisory Partners's AMIX Position: Q3 2025 in Review

Arax Advisory Partners sold out of Autonomix Medical (AMIX) in Q3 2025, closing a stake of 48 shares — an estimated $1.57K sold.

Arax Advisory Partners first reported a position in AMIX in Q2 2025 and held it in 1 quarter. The position peaked at $1.57K in Q2 2025. 14 funds tracked by Wall St. Rank hold AMIX as of Q3 2025.

  • Arax Advisory Partners reported no remaining Autonomix Medical position as of Q3 2025 after selling out during the quarter.
  • Arax Advisory Partners sold 48 Autonomix Medical shares in Q3 2025, an estimated $1.57K.
  • Arax Advisory Partners first reported a position in Autonomix Medical in Q2 2025 and held it in 1 quarter.
  • Arax Advisory Partners's Autonomix Medical position peaked at $1.57K in Q2 2025.
  • 14 funds tracked by Wall St. Rank held Autonomix Medical as of Q3 2025.

Based on Arax Advisory Partners's 13F filing for Q3 2025, filed 14 Nov 2025.